Literature DB >> 33453713

MiR-133a-3p relieves the oxidative stress induced trophoblast cell apoptosis through the BACH1/Nrf2/HO-1 signaling pathway.

H Guo1, Y Wang, W Jia, L Liu.   

Abstract

Preeclampsia (PE) is a major cause of the pregnancy morbidity and mortality over the world. Disorganized placentation caused by trophoblast cell abnormity is one of main risk factors to induce PE. MiR-133a-3p has been shown to contain regulatory effects on oxidative stress in the cardiomyocytes. But the effects of miR-133a-3p on oxidative stress-induced apoptosis in the trophoblast cells remain unknown. In this study, trophoblast HTR-8/SVneo cells were transfected with miR-133a-3p mimics and inhibitor. H2O2 (250 microM) treatment of cells was adopted to induce oxidative stress. A series of typical molecular and cellular experiments was subsequently performed in order to investigate this issue. It was found that miR-133a-3p overexpression attenuated the oxidative stress induced by H2O2 through reduced ROS and MDA levels and enhanced antioxidase activities in the trophoblast cells. Overexpressed miR-133a-3p was shown to relieve the oxidative stress-induced apoptosis of HTR-8/SVneo cells. At molecular levels, a direct binding effect of miR-133a-3p on BACH1 was verified. Moreover, miR-133a-3p overexpression also enhanced BACH1 downstream Nrf2/HO-1 signaling to activate antioxidant genes. It is collectively demonstrated that miR-133a-3p can relieve the oxidative stress-induced apoptosis in the trophoblast cells through the BACH1/Nrf2/HO-1 signaling pathway via targeting BACH1 directly. This regulatory mechanism of miR-133a-3p in the trophoblast cells under oxidative stress may give a new perspective for oxidative stress-induced trophoblast cell abnormality and be useful to study more pathological mechanisms of PE.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33453713      PMCID: PMC8820513          DOI: 10.33549/physiolres.934506

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  26 in total

1.  Novel insights into the regulation of antioxidant-response-element-mediated gene expression by electrophiles: induction of the transcriptional repressor BACH1 by Nrf2.

Authors:  Henna-Kaisa Jyrkkänen; Suvi Kuosmanen; Merja Heinäniemi; Heidi Laitinen; Emilia Kansanen; Eero Mella-Aho; Hanna Leinonen; Seppo Ylä-Herttuala; Anna-Liisa Levonen
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

2.  miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.

Authors:  Yanwei Yin; Lei Du; Xuezhen Li; Xiaoyan Zhang; Yongli Gao
Journal:  J Cell Physiol       Date:  2018-12-10       Impact factor: 6.384

Review 3.  Roles of microRNAs in preeclampsia.

Authors:  Yan Lv; Cheng Lu; Xiaohong Ji; Zhijing Miao; Wei Long; Hongjuan Ding; Mingming Lv
Journal:  J Cell Physiol       Date:  2018-09-06       Impact factor: 6.384

4.  Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.

Authors:  Yu Gong; Jun Ren; Kun Liu; Li-Ming Tang
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

5.  Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Katarina Ivankova; Yulia Vedmetskaya; Ladislav Krofta
Journal:  Int J Cardiol       Date:  2017-12-15       Impact factor: 4.164

6.  High levels of activin A detected in preeclamptic placenta induce trophoblast cell apoptosis by promoting nodal signaling.

Authors:  Ling Yu; Dong Li; Qin-Ping Liao; Hui-Xia Yang; Bin Cao; Guodong Fu; Gang Ye; Yang Bai; Hao Wang; Nana Cui; Ming Liu; Yu-Xia Li; Jun Li; Chun Peng; Yan-Ling Wang
Journal:  J Clin Endocrinol Metab       Date:  2012-06-08       Impact factor: 5.958

Review 7.  Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.

Authors:  Aldo Giudice; Claudio Arra; Maria C Turco
Journal:  Methods Mol Biol       Date:  2010

8.  MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.

Authors:  Yousuke Uchida; Takeshi Chiyomaru; Hideki Enokida; Kazumori Kawakami; Shuichi Tatarano; Kazuya Kawahara; Kenryu Nishiyama; Naohiko Seki; Masayuki Nakagawa
Journal:  Urol Oncol       Date:  2011-03-10       Impact factor: 3.498

Review 9.  Diagnosis and management of atypical preeclampsia-eclampsia.

Authors:  Baha M Sibai; Caroline L Stella
Journal:  Am J Obstet Gynecol       Date:  2008-11-18       Impact factor: 8.661

Review 10.  Pre-eclampsia.

Authors:  Ben W J Mol; Claire T Roberts; Shakila Thangaratinam; Laura A Magee; Christianne J M de Groot; G Justus Hofmeyr
Journal:  Lancet       Date:  2015-09-02       Impact factor: 79.321

View more
  4 in total

1.  [Differential expression profile of miRNAs in amniotic fluid exosomes from fetuses with Down syndrome].

Authors:  K Ding; L Yu; Z Huang; H Zheng; X Yang; T Tian; R Xie
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-02-20

2.  Effects of Stellera chamaejasme on microvascular density and apoptosis of cancer cells in a rat bladder tumor model.

Authors:  Yudong Huang; Jun Zhang; Baolin Zhang; Shuang Chen; Ziyang Qiang; Hailin Ren; Guojun Chen; Chengde Ren
Journal:  Transl Androl Urol       Date:  2022-03

3.  Proteomic analysis of the IPF mesenchymal progenitor cell nuclear proteome identifies abnormalities in key nodal proteins that underlie their fibrogenic phenotype.

Authors:  Libang Yang; Adam Gilbertsen; Karen Smith; Hong Xia; LeeAnn Higgins; Candace Guerrero; Craig A Henke
Journal:  Proteomics       Date:  2022-06-14       Impact factor: 5.393

Review 4.  Insight into the Key Points of Preeclampsia Pathophysiology: Uterine Artery Remodeling and the Role of MicroRNAs.

Authors:  Katarzyna Pankiewicz; Anna Fijałkowska; Tadeusz Issat; Tomasz M Maciejewski
Journal:  Int J Mol Sci       Date:  2021-03-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.